Meltem Demirel Kars

Prof. Dr. Meltem Demirel Kars

Department of Biomedical Engineering, Necmettin Erbakan University, Konya, Turkey (Türkiye)
orcid

Research Focus & Metrics

Academic Career Length

20Years (2007-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 February 2011 in Biomedicine & Pharmacotherapy
Verified
Journal Article
Closed access
ÖIÖzlem Darcansoy Işeri
Özlem Darcansoy Işeri
MKMeltem Demirel Kars
Meltem Demirel Kars
FAFikret Arpaci
Fikret Arpaci
CACan Atalay
Can Atalay
IPIşin Pak
Işin Pak
UGUfuk Gündüz
Ufuk Gündüz

19 June 2010 in Cancer Chemotherapy and Pharmacology
Verified
Journal Article
Closed access
PDF file
YÇYaprak Dönmez Çakıl
Yaprak Dönmez Çakıl
LALaila Akhmetova
Laila Akhmetova
ÖIÖzlem Darcansoy İşeri
Özlem Darcansoy İşeri
MKMeltem Demirel Kars
Meltem Demirel Kars
UGUfuk Gündüz
Ufuk Gündüz

19 June 2009 in Cancer Chemotherapy and Pharmacology
Verified
Journal Article
Closed access
PDF file
ÖİÖzlem Darcansoy İşeri
Özlem Darcansoy İşeri
MKMeltem Demirel Kars
Meltem Demirel Kars
FAFikret Arpaci
Fikret Arpaci
UGUfuk Gündüz
Ufuk Gündüz

10 August 2022 in ACS Biomaterials Science & Engineering
Verified
Journal Article
Closed access
CÇCansu Güneş Çimen
Cansu Güneş Çimen
MDMehmet Akif Dündar
Mehmet Akif Dündar
MKMeltem Demirel Kars
Meltem Demirel Kars
AAAhmet Avcı
Ahmet Avcı

18 June 2008 in Chemotherapy
Verified
Journal Article
Closed access
MKMeltem Demirel Kars
Meltem Demirel Kars
OIOzlem Darcansoy İşeri
Ozlem Darcansoy İşeri
UGUfuk Gunduz
Ufuk Gunduz
JMJozsef Molnar
Jozsef Molnar
Background: Ineffectiveness of anticancer drugs is frequently observed in cancer chemotherapy. The resistance of tumor cells to various cytotoxic drugs is defined as multidrug resistance (MDR). The purpose of this study is to investigate the potential reversal effect of some synthetic and natural chemicals on drug-resistant MCF-7 cell lines. The effects of potential MDR modulators combined with some anticancer drugs were also studied. Methods: Flow cytometry, MTT cytotoxicity assays and checkerboard combination assays were performed to study the reversal of drug resistance and to investigate the antiproliferative effects of the combination of anticancer drugs and the potential modulators. The results indicated that verapamil, capsanthin, zeaxanthin and promethazine inhibited P-gp effectively, but chrysin was not effective at reversing the resistance in MCF-7 sublines. Four selective anticancer drugs (paclitaxel, docetaxel, doxorubicin and vincristine) and 4 effective MDR modulators (verapamil, capsanthin, zeaxanthin and promethazine) were applied to the sublines in combination. Results and Conclusion: Fractional inhibitory indices show that verapamil and zeaxanthin seem to be the most effective MDR reversal agents that may be used together with paclitaxel, docetaxel, vincristine and doxorubicin in drug-resistant mammary carcinoma sublines. In conclusion, this report represents the importance to find out active and efficient drug resistance modulators for improving the efficacy of chemotherapy.

1 September 2010 in Biomedicine & Pharmacotherapy
Verified
Journal Article
Closed access
MKMeltem Demirel Kars
Meltem Demirel Kars
ÖIÖzlem Darcansoy Işeri
Özlem Darcansoy Işeri
UGUfuk Gündüz
Ufuk Gündüz